Press Releases by Category Health & Medicine
Sweden Cardiovascular Therapeutics drugs Market 2023 To Show Startling Growth Du …
The Sweden Cardiovascular Therapeutics drugs Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Sweden Cardiovascular Therapeutics drugs market. This report explores all the key factors affecting the growth of the global…
Egypt Asthma Drug Market Insights and In-Depth Analysis 2023-2028 with Types, Pr …
The Egypt Asthma Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Asthma Drug market. This report explores all the key factors affecting the growth of the global Egypt Asthma…
Egypt HIV Drug Market 2023 | Estimate CAGR Analysis, Technological Development O …
The Egypt HIV Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt HIV Drug market. This report explores all the key factors affecting the growth of the global Egypt HIV…
Egypt Type II Diabetes Mellitus Drug Market Size and Share 2023 | Upcoming Trend …
The Egypt Type II Diabetes Mellitus Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Type II Diabetes Mellitus Drug market. This report explores all the key factors affecting the…
Egypt Diabetes Market Evolution Segmentation and Insight of Trends 2023 to 2028 …
The Egypt Diabetes Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Diabetes market. This report explores all the key factors affecting the growth of the global Egypt Diabetes market, including…
Brazil Metabolic Disorders Therapeutics Market Size, Competitive Landscape, Regi …
Report Overview
The Brazil Metabolic Disorders Therapeutics market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Metabolic disorders usually occur due to disruption of the normal processes of the body. These disorders can be hereditary or acquired and the symptoms differ from person to person. Some metabolic disorders cause mild symptoms that…
Latest Report Of Brazil CNS Therapeutics Market Growth, Opportunities, Risk, Cha …
Report Overview
The Brazil CNS Drugs market size stood at around USD 1.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Central nervous system diseases, is a group of neurological disorders that affects the structure or functioning of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental…
Australia Asthma Drugs Market Growing Trade Among Emerging Economies Opening New …
Report Overview
The Australia Asthma Drugs market size stood at USD 474 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Asthma is a chronic lung disease characterized by narrowing of airways and continual, marked inflammation and in response to specific triggers, which are usually reversible. If the management of the conditions is not done properly, this may elevate…
Australian Anti-Fungal Drugs Market Report with Executive Summary, Size, Analysi …
Report Overview
The Australian Anti-Fungal Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fungal infections represent the invasion of tissues by one or more species of fungi. They range from superficial, localized skin conditions to deeper tissue infections to serious lung, blood (septicemia), or systemic diseases. Some fungi are opportunistic…
Egypt Migraine Drug Market Size, Share, Price, Trends, Growth, Analysis, Outlook …
The Egypt Migraine Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Migraine Drug market. This report explores all the key factors affecting the growth of the global Egypt Migraine…
Egypt Parkinsons Disease Drug Market 2023 Is Ready to Set Outstanding Growth in …
The Egypt Parkinsons Disease Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Parkinsons Disease Drug market. This report explores all the key factors affecting the growth of the global…
According to Latest Report on Australia Anti-Acne Drug Market 2023 to Grow with …
Report Overview
The Australia Anti-Acne Drug market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.
Acne is a very common skin condition. It causes spots and painful bumps on the skin. It is most noticeable on the face, but can also appear on the back, shoulders, and buttocks. Severe acne can cause…
Egypt Osteoporosis Drug Market Growing Trade Among Emerging Economies Opening Ne …
The Egypt Osteoporosis Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Osteoporosis Drug market. This report explores all the key factors affecting the growth of the global Egypt Osteoporosis…
Impact of COVID-19 Outbreak on Australia Parkinsons Disease Drugs Market to Witn …
Report Overview
The Australia Parkinsons Disease Drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Parkinsons disease is a progressive, degenerative neurological condition that affects a persons control of their body movements. It is not contagious or fatal that is, a person cannot die from Parkinsons symptoms. It is thought that the…
Australia Sickle Cell Disease Market 2023 Is Ready to Set Outstanding Growth in …
Report Overview
The Australian sickle cell disease market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Sickle cell disease is a group of inherited red blood cell disorders that affects hemoglobin, the protein that carries oxygen through the body. Normally, red blood cells are disc-shaped and flexible to move easily through the blood…
Australian Spinal Muscular Atrophy Therapeutics Market Growing Trade Among Emerg …
Report Overview
The Australian Spinal Muscular Atrophy Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Spinal Muscular Atrophy (SMA) is a group of genetic neuromuscular disorders that affect the nerve cells that control voluntary muscles (motor neurons). The loss of motor neurons causes progressive muscle weakness and loss of…
Australian Pyruvate Kinase Deficiency Therapeutics Market Business Scenario Anal …
Report Overview
The Australia Pyruvate Kinase Deficiency Disease Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Pyruvate Kinase (PK) Deficiency is an inherited and genetic disorder that affects the red blood cells (RBCs) which is responsible for carrying the oxygen to the body tissue. This condition is also known as…
Australian Fragile-X Syndrome Therapeutics Market Size, Competitive Landscape, R …
Report Overview
The Australian Fragile-X Syndrome Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fragile X Syndrome is characterized by moderate intellectual disability in affected males and mild intellectual disability in affected females. Distinctive physical features are sometimes present in affected males including a large head, long face, prominent forehead…
Latest Report Of Australian Pouchitis Therapeutics Market Growth, Opportunities, …
Report Overview
The Australian Pouchitis Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Pouchitis is an inflammatory condition of the ileal pouch. It happens when the ileal pouch reservoir becomes inflamed or irritated. Pouchitis mainly occurs in a patient who has undergone ileal pouch-anal anastomosis (IPAA), a surgical procedure for…
Australian Fronto Temporal Dementia (FTD) Therapeutics Market Growing Trade Amon …
Report Overview
The Australian Fronto Temporal Dementia Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Frontotemporal Dementia (FTD) is the name given to dementia when it is due to progressive damage to the frontal and/or temporal lobes of the brain. The right and left frontal lobes at the front of…
Australian Friedreich Ataxia Therapeutics Market Report with Executive Summary, …
Report Overview
The Australian Friedreich Ataxia (FRDA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Friedreichs Ataxia (FRDA) is the common inherited ataxia in the Australian. FRDA is a genetic, progressive, neurodegenerative movement disorder, that primarily affects the nervous system and the heart with a typical age of onset between…
Australian Angelman Syndrome Therapeutics Market 2023 : Projected to Deliver Gre …
The Australian Angelman Syndrome Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Angelman syndrome is a rare genetic and neurological disorder characterized by severe developmental delay and learning disabilities; absence or near absence of speech; inability to coordinate voluntary movements (ataxia); tremulousness with jerky movements of the arms and…
Impact of COVID-19 Outbreak on Australian Duchenne Muscular Dystrophy (DMD) Ther …
Report Overview
The Australian Duchenne Muscular Dystrophy Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Duchenne muscular dystrophy, or DMD, is a debilitating genetic condition that causes a gradual loss of muscle function that affects everyday movements and activities. Muscular dystrophyis a condition that causes progressive wasting of the muscles.…
Australian Morquio Syndrome (MPS IV) Therapeutics Market 2023 Is Ready to Set Ou …
Report Overview
The Australian Morquio Syndrome (MPS IV) Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Morquio Syndrome (MPS IV) is an ultra-rare autosomal recessive inherited disorder and a member of a group of hereditary metabolic diseases known as the mucopolysaccharidoses (MPS) which, in turn, are part of a larger…
Egypt Multiple Sclerosis Treatment Market Business Scenario Analysis By Global I …
The Egypt Multiple Sclerosis Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Multiple Sclerosis Treatment market. This report explores all the key factors affecting the growth of the global…
Australia Mucopolysaccharidosis I (MPS I) Therapeutics Market Growing Trade Amon …
Report Overview
The Australian Mucopolysaccharidosis I (MPS I) Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Mucopolysaccharidosis I (MPS I) is a member of a group of hereditary metabolic diseases known as the mucopolysaccharidoses which, in turn, are part of a larger group of diseases known as lysosomal storage disorders…
Egypt Alzheimers Disease Drug Market Size, Competitive Landscape, Regional Outlo …
The Egypt Alzheimers Disease Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Alzheimers Disease Drug market. This report explores all the key factors affecting the growth of the global…
Egypt OTC Drug Market Growing Trade Among Emerging Economies Opening New Opportu …
The Egypt OTC Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt OTC Drug market. This report explores all the key factors affecting the growth of the global Egypt OTC…
Egypt Womens Health Market Report with Executive Summary, Size, Analysis and For …
The Egypt Womens Health Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Womens Health market. This report explores all the key factors affecting the growth of the global Egypt Womens…
Egypt Pain Management Market 2023 : Projected to Deliver Greater Revenues during …
The Egypt Pain Management Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Pain Management market. This report explores all the key factors affecting the growth of the global Egypt Pain…
Australian Pompe Disease (GSDII) Therapeutics Market Business Scenario Analysis …
Report Overview
The Australian Pompe Disease (GSDII) Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Pompe Disease also known as Type II glycogen storage disease (GSDII), is a rare autosomal recessively inherited metabolic disorders caused by the accumulation of glycogen take place in the lysosome that affects people of all…
Australian Gaucher Disease Therapeutics Market Size, Competitive Landscape, Regi …
Report Overview
The Australian Gaucher Disease Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Gaucher disease is a rare, inherited metabolic disorder in which deficiency of the enzyme glucocerebrosidase results in the accumulation of harmful quantities of certain fats (lipids), specifically the glycolipid glucocerebroside, throughout the body especially within the…
Latest Report Of Australian Lysosomal Storage Disorder Therapeutics Market Growt …
Report Overview
The Australian Lysosomal Storage Disorder Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
LSDs usually are caused by a deficiency of a single lysosomal enzyme or protein, which results in a build-up of a lipid (a type of fat) or sugar in the lysosome. There are many lysosomal…
Australian Autoimmune Haemolytic Anaemia (AIHA) Therapeutics Market Growing Trad …
Report Overview
The Australian Autoimmune Haemolytic Anaemia (AIHA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Autoimmune Haemolytic Anaemia (AIHA) is an autoimmune disorder characterised by the premature destruction of healthy red blood cells (RBCs) by auto-antibodies. It is a common disorder directed against self RBCs which can be idiopathic…
Australian Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Report …
Report Overview
The Australian Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Paroxysmal Nocturnal Haemoglobinuria (PNH) is a very rare and debilitating disease of the bone marrow that affects the blood and major organs. It is a chronic, life-threatening illness and can have devastating effects upon a…
Australian Hypophosphatasia (HPP) Treatment Market 2023 : Projected to Deliver G …
Report Overview
The Australian Hypophosphatasia (HPP) Treatment Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Hypophosphatasia (HPP) is also known as Rathbun disease is an ultra-rare metabolic genetic disorder characterized by the abnormal development of bones and teeth due to defective mineralization, a process by which bones and teeth use minerals…
According to Latest Report on Australian Chronic Inflammatory Demyelinating Poly …
Report Overview
The Australian Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder in which there is inflammation of nerve roots and peripheral nerves and destruction of the fatty protective covering(myelin sheath) of the nerve fibres.…
Impact of COVID-19 Outbreak on Australian Interstitial Cystitis Therapeutics Mar …
Report Overview
The Australian Interstitial Cystitis Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Interstitial cystitis (IC) is a subtype of painful bladder syndrome where specific inflammatory changes in the bladder are present at cystoscopy (a telescope examination of the bladder) with biopsy findings that may include increased numbers of…
Australian Transthyretin Amyloidosis (ATTR) Therapeutics Market 2023 Is Ready to …
Report Overview
The Australian Transthyretin Amyloidosis (ATTR) Therapeutics Market size stood at USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Transthyretin Amyloidosis (ATTR) is a progressive and severe orphan disease. ATTR amyloidosis is a medical disorder marked by the formation of abnormal deposits of a protein called amyloid (amyloidosis) in the organs and tissues of the…
Australian Physiotherapy Service Market Growing Trade Among Emerging Economies O …
Report Overview
The Australian Physiotherapy Service market size stood at USD 2.46 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Expanding geriatric population in Australia, higher prevalence and incidences of orthopedic disorders, growing womens healthcare concern, and rise in the awareness among people regarding the advantages of physiotherapy are the prime growth drivers of the Australian physiotherapy services…
Australian In Vitro Diagnostic (IVD) Market Business Scenario Analysis By Global …
Report Overview
The Australian In Vitro Diagnostic (IVD) market size stood at around USD 1.89 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The rise in the prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing cardiac deaths and favorable reimbursement initiatives. Cardiovascular hospitalization rates were 30% higher among those living in remote and very remote…
Australian Telemedicine Market Size, Competitive Landscape, Regional Outlook and …
Report Overview
The Australian Telemedicine market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
Australias vast distances, rugged terrain, and highly urbanized population mean many rural and regional communities are a long way from centralized health resources and specialist hospitals. Telemedicine overcomes the barrier of distance by providing clinical medical care through information…
Latest Report Of Australian Non-Small Cell Lung Cancer (NSCLC) Market Growth, Op …
Report Overview
The Australian NSCLC market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Non-small cell lung cancer (NSCLC) is one of the types of Lung Cancer. About 80% to 85% of lung cancers are NSCLC. The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. These subtypes,…
Australian Prostate Cancer Drugs Market Growing Trade Among Emerging Economies O …
Report Overview
The Australian Prostate Cancer drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Prostate cancer develops when abnormal cells in the prostate gland in an uncontrolled way, forming a malignant tumor. In 2016, 19,305 new cases of prostate cancer were diagnosed in Australia. Early (localized) prostate cancer refers to…
Australian Ovarian Cancer Market Report with Executive Summary, Size, Analysis a …
Report Overview
The Australian Ovarian Cancer market size stood at around USD 52.19 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Ovarian cancer is a type of cancer that mainly occurs in the reproductive part of the womenThis condition is characterized by abnormal growth of cells in the ovaries, which has the potential to destroy other body parts…
Australian Lung Cancer Drugs Market 2023 : Projected to Deliver Greater Revenues …
Report Overview
The Australian Lung Cancer drugs market size stood at around USD 0.59 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Lung cancer is the fifth most common cancer in Australia and accounts for 9% of all cancers. It was estimated that there would be 3,258 new cases of lung cancer diagnosed in Australia in 2020. The…
According to Latest Report on Australian Colorectal Cancer Drugs Market 2023 to …
Report Overview
The Australian Colorectal Cancer drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, and is any form of cancer that affects the colon and the Colorectal cancer was the 3rd most diagnosed cancer in Australia in 2016.…
Impact of COVID-19 Outbreak on Australian Brain Cancer Market to Witness a Prono …
Report Overview
The Australian Brain Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Brain cancers include primary brain tumors, which start in the brain and almost never spread to other parts of the body, and secondary tumors (or metastases), which are caused by cancers that began in another part of…
Australian Vaccines Market 2023 Is Ready to Set Outstanding Growth in Upcoming Y …
Report Overview
The Australian Vaccines market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Vaccines, also known as immunizations, inject a weakened form of a disease into a person so the body begins producing antibodies or immunity against the disease. Effective immunization has eradicated several diseases, like polio and smallpox, with high…
Australian Respiratory Devices Market Growing Trade Among Emerging Economies Ope …
Report Overview
The Australian Respiratory Devices market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Two major chronic respiratory diseases in Australia are chronic obstructive pulmonary disease (COPD) and asthma. With about 5,400 deaths attributed to it in 2003, COPD is a major cause of death in Australia. The rise in the…
Go To Page 7918 7917 7916 7915 7914 7913 7912 7911 7910 7909
